Hepatology Nurse Practitioner, SCTI Liver Center Research Foundation, Southern California Liver Centers, 2004 (December)
Faculty-Associate Professor, Azusa Pacific University, Azusa CA, 2002
Meet the Faculty
Professional Experience of
Anna Marie Hefner, MSN, MAEd, CPNP, RN
Back to Profile
Academic Experience
Clinical Work
A Phase 3, randomized, open-label study of the safety and efficacy of two dose levels of Interferon Alfacon-1 plus Ribavirin administered daily for 48 weeks versus no-treatment in Hepatitis C infection patients who are nonresponders to previous Pegylated Interferon plus Ribavirin therapy. Sponsored by Intermune. Sub-investigator. March 2005.
Randomized double blind multi-center study to compare the safety and efficacy of viramidine to ribavirin in treatment naïve patients with chronic hepatitis C. Sponsored by Ribapharm. Sub-investigator. March 2004.
Randomized double blind multi-center study to compare the safety and efficacy of viramidine to ribavirin in treatment naïve patients with chronic hepatitis C. Sponsored by Ribapharm. Sub-investigator. March 2004.
Industry Experience
Impact - Topics in Gastroenterology, December 2006
Challenges in Treating Special Populations: Nonresponders, Acute Infection, African Americans, and HIV Coinfected Patients, Colorado Nurses Association, June 2005
Coinfection Community Training Program, “Managing, Caring and Treating Patients Coinfected with HCV, HBV, and HIV”, San Franciso CA, April 2005
Hepatitis C Treatment: Today and Tomorrow, Northwestern University, June 2005
Intermune Hepatology Regional Advisory Board “Nonresponders: What’s Next?”, Laguna Beach CA, April 2005
Management of HCV-Associated Fibrosis, Northwestern University, June 2005
Management of Hepatitis C and Managing Side Effects: A Team-based Approach to Treatment, Colorado Nurses Association, June 2005
Back to ProfileChallenges in Treating Special Populations: Nonresponders, Acute Infection, African Americans, and HIV Coinfected Patients, Colorado Nurses Association, June 2005
Coinfection Community Training Program, “Managing, Caring and Treating Patients Coinfected with HCV, HBV, and HIV”, San Franciso CA, April 2005
Hepatitis C Treatment: Today and Tomorrow, Northwestern University, June 2005
Intermune Hepatology Regional Advisory Board “Nonresponders: What’s Next?”, Laguna Beach CA, April 2005
Management of HCV-Associated Fibrosis, Northwestern University, June 2005
Management of Hepatitis C and Managing Side Effects: A Team-based Approach to Treatment, Colorado Nurses Association, June 2005
